Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222

Hyaluronan: from extracellular glue to pericellular cue

Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Screaton, G. R., Bell, M. V., Jackson, D. G., Cornélis, F., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,016

Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis

Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

Bashkin, P., Doctrow, S. R., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590

The Global Breast Cancer Burden: Variations in Epidemiology and Survival

Hortobágyi, G. N., Salazar, J. D. L. G., Pritchard, K. I., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H. M., Liu, M.-C., Martín, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586

Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis

Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 535

Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival

Auvinen, P., Tammi, R., Parkkinen, J. J., Tammi, M., Ågren, U. M., Johansson, R. T., Hirvikoski, P. P., Eskelinen, M. J., & Kosma, V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 494

Recent advances in tumor-targeting anticancer drug conjugates

Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 491

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Creighton, C. J., Li, X., Landis, M. D., Dixon, J. M., Neumeister, V. M., Sjolund, A. B., Rimm, D. L., Wong, H. H., Rodriguez, A. A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,414

Significance of CD90+ Cancer Stem Cells in Human Liver Cancer

Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188

Fibroblast heterogeneity in the cancer wound

Öhlund, D., Elyada, E., & Tuveson, D. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 982

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M. V., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 922

Interstitial Fluid and Lymph Formation and Transport: Physiological Regulation and Roles in Inflammation and Cancer

Wiig, H., & Swartz, M. A. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2011 · Cited by 739

Conquering the Hypoxia Limitation for Photodynamic Therapy

Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705

Targeting and delivery of platinum-based anticancer drugs

Wang, X., & Guo, Z. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35259a · Cited by 693

ATP-triggered anticancer drug delivery

Mo, R., Jiang, T., DiSanto, R., Tai, W., & Gu, Z. (2014) · Nature Communications · doi:10.1038/ncomms4364 · Cited by 693

Endogenous toll‐like receptor ligands and their biological significance

Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 555

CD44, a therapeutic target for metastasising tumours

Orian‐Rousseau, V. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.024 · Cited by 476

TLR signaling by tumor and immune cells: a double-edged sword

Huang, B., Zhao, J., Unkeless, J. C., Feng, Z., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377

Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor

Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375

Interstitial guidance of cancer invasion

Gritsenko, P. G., Ilina, O., & Friedl, P. (2011) · The Journal of Pathology · doi:10.1002/path.3031 · Cited by 368

Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis

Pawelek, J. M., & Chakraborty, A. K. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2371 · Cited by 328

The activation and physiological functions of the proprotein convertases

Seidah, N. G., Mayer, G., Zaid, A., Rousselet, E., Nassoury, N., Poirier, S., Essalmani, R., & Prat, A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.030 · Cited by 314

Breast cancer metastasis

Scully, O. J., Bay, B., Yip, G., & Yu, Y. (1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 294

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

Jain, V. K., Kumar, H., Anod, H. V., Chand, P., Gupta, N., Dey, S., & Kesharwani, S. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.003 · Cited by 295

Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments

Kolaříková, M., Hošíková, B., Dilenko, H., Tomankova, K. B., Válková, L., Bajgar, R., Malina, L., & Kolářová, H. (2023) · Medicinal Research Reviews · doi:10.1002/med.21935 · Cited by 294

Chemical Synthesis of Glycosaminoglycans

Mende, M., Bednarek, C., Wawryszyn, M., Sauter, P. F., Biskup, M. B., Schepers, U., & Bräse, S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00010 · Cited by 287

Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy

Hu, C., Cun, X., Ruan, S., Liu, R., Xiao, W., Yang, X., Yang, Y., Yang, C., & Gao, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.046 · Cited by 277

Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution

Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b900456d · Cited by 272

The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells

Hamilton, S. R., Fard, S. F., Paiwand, F. F., Tölg, C., Veiseh, M., Wang, C., McCarthy, J. B., Bissell, M. J., Koropatnick, J. D., & Turley, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702078200 · Cited by 263

Hyaluronic acid and albumin based nanoparticles for drug delivery

Lei, C., Liu, X.-R., Chen, Q., Li, Y., Zhou, J., Zhou, L.-Y., & Zou, T. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.033 · Cited by 271

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme

Bradshaw, A., Wickremsekera, A., Tan, S. T., Peng, L., Davis, P. F., & Itinteang, T. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00021 · Cited by 277

Risk of Cancer in Patients With Autoimmune Pancreatitis

Shiokawa, M., Kodama, Y., Yoshimura, K., Kawanami, C., Mimura, J., Yamashita, Y., Asada, M., Kikuyama, M., Okabe, Y., Inokuma, T., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.465 · Cited by 254

High numbers of macrophages, especially M2‐like ( CD 163‐positive), correlate with hyaluronan accumulation and poor outcome in breast cancer

Tiainen, S., Tumelius, R., Rilla, K. J., Hämäläinen, K. M., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2014) · Histopathology · doi:10.1111/his.12607 · Cited by 234

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

Maxwell, C. A., McCarthy, J. B., & Turley, E. A. (2008) · Journal of Cell Science · doi:10.1242/jcs.022038 · Cited by 228

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

Olsson, E., Honeth, G., Bendahl, P., Saal, L. H., Gruvberger-Saal, S. K., Ringnér, M., Vallon‐Christersson, J., Jönsson, G. B., Holm, K., Lövgren, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-418 · Cited by 205

Proteomic Analysis of Microvesicles Derived from Human Colorectal Cancer Cells

Choi, D., Lee, J., Park, G. W., Lim, H.-W., Bang, J. Y., Kim, Y., Kwon, K., Kwon, H. J., Kim, K. P., & Gho, Y. S. (2007) · Journal of Proteome Research · doi:10.1021/pr070192y · Cited by 205

Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy

Wang, S., Zhang, J., Wang, Y., & Chen, M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.014 · Cited by 187

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

Nikolova, V. D., Koo, C.-Y., Ibrahim, S., Wang, Z., Spillmann, D., Dreier, R., Kelsch, R., Fischgräbe, J., Smollich, M., Rossi, L. H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp001 · Cited by 185

CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel

Muntimadugu, E., Kumar, R., Shantikumar, S., Rafeeqi, T. A., & Khan, W. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.075 · Cited by 184

The impact of tumour pH on cancer progression: strategies for clinical intervention

Ward, C., Meehan, J., Gray, M., Murray, A. F., Argyle, D. J., Kunkler, I. H., & Langdon, S. P. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00005 · Cited by 180

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer

Liang, Y., Wang, Y., Wang, L., Liang, Z., Li, D., Xu, X., Chen, Y., Yang, X., Zhang, H., & Niu, H. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.019 · Cited by 101

Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis

Chu, H., Gao, J., Chen, C.-W., Huard, J., & Wang, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110121108 · Cited by 176

Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells

Bourguignon, L., Xia, W., & Wong, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806708200 · Cited by 175

The role of the microenvironment in tumor growth and invasion

Kim, Y., Stolarska, M., & Othmer, H. G. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2011.06.006 · Cited by 181

A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells

Zhang, M., Xu, C., Wen, L., Han, M. K., Xiao, B., Zhou, J., Zhang, Y., Zhang, Z., Viennois, É., & Merlin, D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1681 · Cited by 172

Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer

Choi, K. Y., Jeon, E. J., Yoon, H. Y., Lee, B. S., Na, J. H., Min, K. H., Kim, S. Y., Myung, S., Lee, S., Chen, X. S., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.029 · Cited by 168

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer

Cai, S., Thati, S., Bagby, T. R., Diab, H.-M., Davies, N. M., Cohen, M. S., & Forrest, M. L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.006 · Cited by 165

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine

Theocharis, A. D., Skandalis, S. S., Neill, T., Multhaupt, H. A. B., Hubo, M., Frey, H., Gopal, S., Gomes, A. M., Afratis, N. A., Lim, H. C., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.006 · Cited by 162

Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism

Ibrahim, S., Yip, G. W., Stock, C. M., Pan, J., Neubauer, C., Poeter, M., Pupjalis, D., Koo, C.-Y., Kelsch, R., Schüle, R., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27629 · Cited by 156

A review of polysaccharide cytotoxic drug conjugates for cancer therapy

Goodarzi, N., Varshochian, R., Kamalinia, G., Atyabi, F., & Dinarvand, R. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.10.036 · Cited by 153

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

Marangoni, E., Lecomte, N., Durand, L., Pinieux, G. D. B. D., Decaudin, D., Chomienne, C., Smadja‐Joffe, F., & Poupon, M. F. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604953 · Cited by 157

Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors

Porter, C. E., Shaw, A. R., Jung, Y., Yip, T., Castro, P. D., Sandulache, V. C., Sikora, A. G., Gottschalk, S. M., Ittman, M. M., Brenner, M. K., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.02.016 · Cited by 147

The state of CD44 activation in cancer progression and therapeutic targeting

Guo, Q., Yang, C., & Gao, F. (2021) · FEBS Journal · doi:10.1111/febs.16179 · Cited by 144

In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver

Ouhtit, A., Elmageed, Z. Y. A., Abdraboh, M. E., Lioe, T. F., & Raj, M. H. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070535 · Cited by 139

CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway

Jijiwa, M., Demir, H., Gupta, S., Leung, C., Joshi, K., Orozco, N. M., Huang, T., Yildiz, V. O., Shibahara, I., Jesus, J. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024217 · Cited by 138

Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc

Paulson, K. G., Lemos, B. D., Feng, B., Jaimes, N., Fernández‐Peñas, P., Bi, X., Maher, E. A., Cohen, L., Leonard, J. H., Granter, S. R., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.365 · Cited by 136

Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma

Liu, H., Korc, M., & Lin, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.012 · Cited by 134

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

Krishnamachary, B., Penet, M., Nimmagadda, S., Mironchik, Y., Raman, V., Solaiyappan, M., Semenza, G. L., Pomper, M. G., & Bhujwalla, Z. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044078 · Cited by 132

Intralymphatic Chemotherapy Using a Hyaluronan–Cisplatin Conjugate

Cai, S., Xie, Y., Bagby, T. R., Cohen, M. S., & Forrest, M. L. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.048 · Cited by 132

CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration

Zen, K., Liu, D.-Q., Guo, Y.-L., Wang, C., Shan, J., Fang, M. L., Zhang, C., & Liu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001826 · Cited by 128

Function of cancer cell-derived extracellular matrix in tumor progression

Xiong, G., & Xu, R. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.08 · Cited by 129

The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation

Khurana, S. S., Riehl, T. E., Moore, B. D., Fassan, M., Rugge, M., Romero–Gallo, J., Noto, J. M., Peek, R. M., Stenson, W. F., & Mills, J. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445551 · Cited by 125

Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy

Liang, X., Fang, L., Li, X., Zhang, X., & Wang, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.006 · Cited by 119

Toll-like receptors: lessons to learn from normal and malignant human B cells

Chiron, D., Bekeredjian‐Ding, I., Pellat‐Deceunynck, C., Bataille, R., & Jégo, G. (2008) · Blood · doi:10.1182/blood-2008-02-140673 · Cited by 118

Therapeutic applications of hyaluronan

Gaffney, J. J., Matou‐Nasri, S., Grau-Olivares, M., & SLEVIN, M. A. (2009) · Molecular BioSystems · doi:10.1039/b910552m · Cited by 118

IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma

Frederiksen, K. S., Lundsgaard, D., Freeman, J. A., Hughes, S. D., Holm, T. L., Skrumsager, B. K., Petri, A., Hansen, L. T., McArthur, G. A., Davis, I. D., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0479-4 · Cited by 117

A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity

Hu, J., Li, G., Zhang, P., Zhuang, X., & Hu, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.72 · Cited by 115

Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging

Lim, E., Kim, H., Jang, E., Park, J., Lee, K., Suh, J., Huh, Y., & Haam, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.077 · Cited by 113

Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44

Golshani, R., López, L. E., Estrella, V. C., Kramer, M. W., Iida, N., & Lokeshwar, V. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2140 · Cited by 112

New Findings on Breast Cancer Stem Cells: A Review

Bozorgi, A., Khazaei, M., & Khazaei, M. R. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.4.303 · Cited by 110

Tumor‐Specific Self‐Degradable Nanogels as Potential Carriers for Systemic Delivery of Anticancer Proteins

Zhu, Q., Chen, X., Xu, X., Zhang, Y., Zhang, C., & Mo, R. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707371 · Cited by 105

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer

Cho, Y., Lee, H.-W., Kang, H.-G., Kim, H., Kim, S.-J., & Chun, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3325 · Cited by 106

Fish oil prevents breast cancer cell metastasis to bone

Mandal, C. C., Ghosh-Choudhury, T., Yoneda, T., Choudhury, G. G., & Ghosh‐Choudhury, N. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.063 · Cited by 104

The Platin-X series: activation, targeting, and delivery

Basu, U., Banik, B., Wen, R. M., Pathak, R., & Dhar, S. (2016) · Dalton Transactions · doi:10.1039/c6dt01738j · Cited by 101

Prognostic relevance of glycosylation-associated genes in breast cancer

Milde‐Langosch, K., Karn, T., Schmidt, M., zu Eulenburg, C., Oliveira‐Ferrer, L., Wirtz, R. M., Schumacher, U., Witzel, I., Schütze, D., & Müller, V. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2949-z · Cited by 98

Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models

Ganesh, S., Gonzalez-Edick, M., Gibbons, D., Roey, M. V., & Jooss, K. U. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4732 · Cited by 95

Importance of Hyaluronan-CD44 Interactions in Inflammation and Tumorigenesis

Heldin, P., Karousou, E., Olofsson, B., Porsch, H., Nishitsuka, K., & Skandalis, S. S. (2008) · Connective Tissue Research · doi:10.1080/03008200802143323 · Cited by 94

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells

He, L., Gu, J. H., Lim, L. Y., Yuan, Z., & Mo, J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00313 · Cited by 94

Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy

Ma, M., Chen, H., Chen, Y., Zhang, K., Wang, X., Cui, X., & Shi, J. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm15489g · Cited by 93

Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion

Qazi, H., Palomino, R., Shi, Z., Munn, L. L., & Tarbell, J. M. (2013) · Integrative Biology · doi:10.1039/c3ib40057c · Cited by 92

Light-Responsive Prodrug-Based Supramolecular Nanosystems for Site-Specific Combination Therapy of Cancer

Phua, S. Z. F., Xue, C., Lim, W. Q., Yang, G., Chen, H., Zhang, Y., Wijaya, C. F., Luo, Z. Y., & Zhao, Y. (2019) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b00439 · Cited by 91

A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer

So, J. Y., Lee, H. J., Smolarek, A. K., Paul, S., Wang, C., Maehr, H., Uskoković, M. R., Zheng, X., Conney, A. H., Cai, L., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068403 · Cited by 90

Hyaluronan-Based Nanocarriers with CD44-Overexpressed Cancer Cell Targeting

Song, S., Qi, H., Xu, J., Guo, P., Chen, F., Li, F., Yang, X., Sheng, N., Wu, Y., & Pan, W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1393-4 · Cited by 89

DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA

Rahman, M. M., Veigas, J. M., Williams, P. J., & Fernandes, G. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2703-y · Cited by 89

Overexpression of Extracellular Superoxide Dismutase Attenuates Heparanase Expression and Inhibits Breast Carcinoma Cell Growth and Invasion

Teoh-Fitzgerald, M. L. T., Fitzgerald, M. P., Oberley, L. W., & Domann, F. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1195 · Cited by 89

PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis

Jilaveanu, L. B., Parisi, F., Barr, M. L., Zito, C. R., Cruz‐Muñoz, W., Kerbel, R. S., Rimm, D. L., Bosenberg, M., Halaban, R., Kluger, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0861 · Cited by 88

Shed proteoglycans in tumor stroma

Piperigkou, Z., Mohr, B., Karamanos, N. K., & Götte, M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2452-4 · Cited by 90

Physical Biology in Cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells

Mitchell, M. J., & King, M. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00285.2013 · Cited by 86

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

Inoue, K., & Fry, E. A. (2015) · Genetics & Epigenetics · doi:10.4137/geg.s35500 · Cited by 84

MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma

Bailey, S. T., Smith, A. M., Kardos, J., Wobker, S. E., Wilson, H. L., Krishnan, B., Saito, R., Lee, H. J., Zhang, J., Eaton, S. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15770 · Cited by 86

Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

Dedes, P. G., Gialeli, C., Tsonis, A., Kanakis, I., Theocharis, A. D., Kletsas, D., Tzanakakis, G. N., & Karamanos, N. K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.013 · Cited by 81

Methylation‐regulated miR‐149 modulates chemoresistance by targeting Glc NA c N‐deacetylase/N‐sulfotransferase‐1 in human breast cancer

He, D., Gu, X., Li, Y., Li, J., Jin, J., & Ma, X. (2014) · FEBS Journal · doi:10.1111/febs.13012 · Cited by 78

CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity

Montgomery, N., Hill, A., McFarlane, S., Neisen, J., O’Grady, A., Conlon, S. J., Jirström, K., Kay, E. W., & Waugh, D. J. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3199 · Cited by 83

Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi

Feng, L., Gao, R., & Gopalakrishnakone, P. (2008) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2008.06.003 · Cited by 77

Comparative transcriptomic and proteomic analyses provide insights into the key genes involved in high-altitude adaptation in the Tibetan pig

Zhang, B., Chamba, Y., Shang, P., Wang, Z., Ma, J., Wang, L., & Zhang, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-03976-3 · Cited by 78

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients

Li, Z., Chen, K., Jiang, P., Zhang, X., Li, X., & Li, Z. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-79 · Cited by 75

Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors

Boxberg, M., Götz, C., Haidari, S., Dorfner, C., Jesinghaus, M., Drecoll, E., Boskov, M., Wolff, K. D., Weichert, W., Haller, B., et al. (2018) · Histopathology · doi:10.1111/his.13496 · Cited by 74

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer

Xu, H., Wu, K., Tian, Y., Liu, Q., Han, N., Yuan, X., Zhang, L., Wu, G. S., & Wu, K. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3639 · Cited by 74

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Shen, Y., & Li, W. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s169734 · Cited by 74

MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism

Ma, Q., Jiang, Q., Pu, Q., Zhang, X., Yang, W., Wang, Y., Ye, S., Wu, S., Zhong, G., Ren, J., et al. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6623 · Cited by 76

STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer

Cavalcante, R. S., Ishikawa, U., Silva, E. S., da Silva-Júnior, A. A., de Araújo, A. A., Cruz, L. J., Chan, A. B., & Júnior, R. F. D. A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15373 · Cited by 73

A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells

Zhou, S., Shang, Q., Ji, J., & Luan, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16154 · Cited by 74

HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation

Duan, T., Xu, Z., Sun, F., Wang, Y., Zhang, J., Luo, C., & Wang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109121 · Cited by 73

Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight

Park, W., Kim, K. S., Bae, B.-C., Kim, Y.-H., & Na, K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.04.008 · Cited by 70

Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer

So, J. Y., Smolarek, A. K., Salerno, D. M., Maehr, H., Uskoković, M. R., Liu, F., & Suh, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054020 · Cited by 70

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

Hiscox, S., Baruah, B. P., Smith, C. R., Bellerby, R., Goddard, L., Jordan, N., Poghosyan, Z. P., Nicholson, R. I., Barrett-Lee, P. J., & Gee, J. M. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-458 · Cited by 70

Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles

Dai, Y., Yu, X. M., Wei, J., Zeng, F., Li, Y., Yang, X., Luo, Q., & Zhang, Z. (2020) · Light Science & Applications · doi:10.1038/s41377-020-00399-0 · Cited by 69

Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression

Gomes, A. M., Stelling, M. P., & Pavão, M. S. G. (2013) · BioMed Research International · doi:10.1155/2013/852093 · Cited by 62

Heparanase promotes growth, angiogenesis and survival of primary breast tumors

Cohen, I., Pappo, O., Elkin, M., San, T., Bar‐Shavit, R., Hazan, R. B., Peretz, T., Vlodavsky, I., & Abramovitch, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21552 · Cited by 135

Review Article Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression

Gomes, A. M., Stelling, M. P., & Pavão, M. S. G. (2013)

Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data

Sun, X., Zhang, G., Nian, J., Yu, M., Chen, S.-J., Zhang, Y., Yang, G., Yang, L., Cheng, P., Chen, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16575 · Cited by 42

Role of CD44 and its main ligand, hyaluronan, in breast cancer invasion

Herrera‐Gayol, A. (2000) · eScholarship@McGill (McGill) · doi:10.82308/52460